Shandong Linuo Pharmaceutical Packaging301188.SZValuation Analysis

As of Oct 19, 2026, Shandong Linuo Pharmaceutical Packaging (301188.SZ) trades at a P/E of 238.00x, P/B of 3.64x, P/S of 5.28x, and a dividend yield of 0.37%.
Longitudinal percentile comparison: P/E sits at the 89th percentile over the trailing 10Y window (vs. 83rd percentile over 3Y); P/B sits at the 81st percentile over the trailing 10Y window (vs. 77th percentile over 3Y); P/S sits at the 76th percentile over the trailing 10Y window (vs. 77th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 92nd percentile within its industry and the 93rd percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 1.51%, ranking at the 75th percentile over the trailing 20Y window.
The P/E and P/B long-window percentiles differ by only 7.8 points, pointing to a consistent valuation read across both metrics. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Breaking down the total shareholder yield: 0.37% comes from cash dividends, with an implied ~1.14% from buybacks — a fairly balanced mix of both channels. Shandong Linuo Pharmaceutical Packaging operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.